The IRF family of transcription factors
Open Access
- 4 November 2012
- journal article
- Published by Informa UK Limited in OncoImmunology
- Vol. 1 (8), 1376-1386
- https://doi.org/10.4161/onci.22475
Abstract
Members of the interferon-regulatory factor (IRF) proteins family were originally identified as transcriptional regulators of the Type I interferon system. Thanks to consistent advances made in our understanding of the immunobiology of innate receptors, it is now clear that several IRFs are critical for the elicitation of innate pattern recognition receptors, and—as a consequence—for adaptive immunity. In addition, IRFs have attracted great attentions as they modulate cellular responses that are involved in tumorigenesis. The regulation of oncogenesis by IRFs has important implications for understanding the host susceptibility to several Types of cancers, their progression, as well as the potential for therapeutic interventions.Keywords
This publication has 127 references indexed in Scilit:
- IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytesThe EMBO Journal, 2011
- Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancerBreast Cancer Research and Treatment, 2009
- Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomasLeukemia, 2008
- Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKɛ-mediated IRF activationThe EMBO Journal, 2008
- IRF4 addiction in multiple myelomaNature, 2008
- The Feedback Phase of Type I Interferon Induction in Dendritic Cells Requires Interferon Regulatory Factor 8Immunity, 2007
- The IRF family, revisitedBiochimie, 2007
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- Interferon regulatory factor-3 is an in vivo target of DNA-PKProceedings of the National Academy of Sciences of the United States of America, 2002
- Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activityOncogene, 1997